{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:35:08Z","timestamp":1777905308420,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.trsl.2020.09.003","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T03:55:05Z","timestamp":1600746905000},"page":"69-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay"],"prefix":"10.1016","volume":"229","author":[{"given":"Yvonne","family":"Sundstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Mei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeepta Kumar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Gr\u00f6nwall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Wermeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Johan","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2020.09.003_bib0001","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1021\/ja109663g","article-title":"Tuning the morphology of gold clusters by substrate doping","volume":"133","author":"Mammen","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.trsl.2020.09.003_bib0002","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3389\/fimmu.2019.02237","article-title":"Genetic Variation in Low-To-Medium-Affinity Fcgamma Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine","volume":"10","author":"Nagelkerke","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0003","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12929-018-0436-2","article-title":"Toll-like receptors in lupus nephritis","volume":"25","author":"Devarapu","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.trsl.2020.09.003_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2020.09.003_bib0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/imr.12741","article-title":"Extrafollicular responses in humans and SLE","volume":"288","author":"Jenks","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2020.09.003_bib0006","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.23498","article-title":"Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95","volume":"58","author":"Jacobi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2020.09.003_bib0007","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","article-title":"A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus","volume":"178","author":"Wei","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0008","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","article-title":"Targeting B Cells and Plasma Cells in Autoimmune Diseases","volume":"9","author":"Hofmann","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0009","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/annrheumdis-2014-206016","article-title":"The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus","volume":"74","author":"Alexander","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2020.09.003_bib0010","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/14397595.2018.1432331","article-title":"Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus","volume":"28","author":"Ishii","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0011","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.09.003_bib0012","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nchembio.1867","article-title":"The promise and peril of chemical probes","volume":"11","author":"Arrowsmith","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41467-018-07905-4","article-title":"A chemical biology toolbox to study protein methyltransferases and epigenetic signaling","volume":"10","author":"Scheer","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2020.09.003_bib0014","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/s41467-019-09672-2","article-title":"A chemical toolbox for the study of bromodomains and epigenetic signaling","volume":"10","author":"Wu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2020.09.003_bib0015","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2020.09.003_bib0016","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2020.09.003_bib0017","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus","volume":"165","author":"Odendahl","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0018","doi-asserted-by":"crossref","first-page":"e96795","DOI":"10.1172\/jci.insight.96795","article-title":"Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus","volume":"3","author":"Gies","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2020.09.003_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2016.10.005","article-title":"Impact of tofacitinib treatment on human B-cells in vitro and in vivo","volume":"77","author":"Rizzi","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trsl.2020.09.003_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1101\/gad.320192.118","article-title":"Molecular regulation of peripheral B cells and their progeny in immunity","volume":"33","author":"Boothby","year":"2019","journal-title":"Gene Dev"},{"key":"10.1016\/j.trsl.2020.09.003_bib0021","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/cmi.2017.133","article-title":"Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity","volume":"15","author":"Wu","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0022","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.41083","article-title":"Epigenetic Defects in the B cell lineage of Systemic Lupus Erythematosus Patients Display Population-Specific Patterns","volume":"72","author":"Breitbach","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0023","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41590-019-0419-9","article-title":"Epigenetic programming underpins B cell dysfunction in human SLE","volume":"20","author":"Scharer","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0024","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","article-title":"Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program","volume":"17","author":"Shaffer","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2020.09.003_bib0025","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1074-7613(03)00267-X","article-title":"Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells","volume":"19","author":"Shapiro-Shelef","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2020.09.003_bib0026","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.4049\/jimmunol.172.9.5427","article-title":"Modular nature of Blimp-1 in the regulation of gene expression during B cell maturation","volume":"172","author":"Sciammas","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0027","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.coi.2008.04.010","article-title":"Activation-dependent induction of Blimp-1","volume":"20","author":"Calame","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0028","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1074\/jbc.M116.713842","article-title":"Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3","volume":"291","author":"Tanaka","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.09.003_bib0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ni1046","article-title":"PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing","volume":"5","author":"Gyory","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncb1413","article-title":"Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells","volume":"8","author":"Ancelin","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0031","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41467-018-07884-6","article-title":"PRMT5 is essential for B cell development and germinal center dynamics","volume":"10","author":"Litzler","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2020.09.003_bib0032","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1182\/blood-2018-02-831438","article-title":"PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival","volume":"132","author":"Lu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.09.003_bib0033","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni.3349","article-title":"Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation","volume":"17","author":"Minnich","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0034","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.181.1.485","article-title":"Functional analysis of histone methyltransferase g9a in B and T lymphocytes","volume":"181","author":"Thomas","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2015.01.010","article-title":"BRAD4 plays a critical role in germinal center response by regulating Bcl-6 and NF-kappaB activation","volume":"294","author":"Gao","year":"2015","journal-title":"Cell Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0036","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1093\/nar\/gky281","article-title":"The KDM4A\/KDM4C\/NF-kappaB and WDR5 epigenetic cascade regulates the activation of B cells","volume":"46","author":"Hung","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2020.09.003_bib0037","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.1701470","article-title":"EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production","volume":"200","author":"Guo","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0038","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.40931","article-title":"Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL\/lpr Mice","volume":"71","author":"Rohraff","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0039","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41467-018-04125-8","article-title":"Plasma cell differentiation is controlled by multiple cell division-coupled epigenetic programs","volume":"9","author":"Scharer","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2020.09.003_bib0040","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s41375-019-0392-1","article-title":"EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation","volume":"33","author":"Herviou","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.trsl.2020.09.003_bib0041","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1084\/jem.179.2.757","article-title":"Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3","volume":"179","author":"Briere","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2020.09.003_bib0042","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes","volume":"89","author":"Rousset","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.09.003_bib0043","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1172\/JCI116977","article-title":"Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein","volume":"93","author":"Levy","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2020.09.003_bib0044","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/eji.201646574","article-title":"B-cell activation with CD40L or CpG measures the function of B-cell subsets and identifies specific defects in immunodeficient patients","volume":"47","author":"Marasco","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0045","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.4049\/jimmunol.1402425","article-title":"Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR\/TLR7-dependent responses","volume":"194","author":"Nundel","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.09.003_bib0046","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5281823","article-title":"Comparative In Vitro Immune Stimulation Analysis of Primary Human B Cells and B Cell Lines","volume":"2016","author":"Van Belle","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.trsl.2020.09.003_bib0047","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/art.40396","article-title":"Abnormal B Cell Development in Systemic Lupus Erythematosus: What the Genetics Tell Us","volume":"70","author":"Karrar","year":"2018","journal-title":"Arthritis Rheumatol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420302255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420302255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:41:28Z","timestamp":1761828088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524420302255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":47,"alternative-id":["S1931524420302255"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2020.09.003","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.01.08.898270","asserted-by":"object"}]},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}